Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Xenopus laevis SH3 domain-binding protein 5-like (sh3bp5l) CSB-YP719465XBE
CSB-EP719465XBE
CSB-BP719465XBE
CSB-MP719465XBE
CSB-EP719465XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Uncharacterized protein C12orf60 (C12orf60) CSB-YP719466HU
CSB-EP719466HU
CSB-BP719466HU
CSB-MP719466HU
CSB-EP719466HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hordeum vulgare Horcolin CSB-YP719467HWQ
CSB-EP719467HWQ
CSB-BP719467HWQ
CSB-MP719467HWQ
CSB-EP719467HWQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bombyx mori 40S ribosomal protein S14 (RpS14) CSB-YP719468BTT
CSB-EP719468BTT
CSB-BP719468BTT
CSB-MP719468BTT
CSB-EP719468BTT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Phosphoinositide 3-kinase regulatory subunit 6 (PIK3R6) CSB-YP719469HU
CSB-EP719469HU
CSB-BP719469HU
CSB-MP719469HU
CSB-EP719469HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rat Cyclic AMP-responsive element-binding protein 3-like protein 4 (Creb3l4), partial CSB-YP719470RA
CSB-EP719470RA
CSB-BP719470RA
CSB-MP719470RA
CSB-EP719470RA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fragaria ananassa Allergen Fra a 1, partial CSB-YP719472FEZ
CSB-EP719472FEZ
CSB-BP719472FEZ
CSB-MP719472FEZ
CSB-EP719472FEZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acanthamoeba polyphaga mimivirus Putative SET domain-containing protein L678 (MIMI_L678) CSB-YP719473ADAZ
CSB-EP719473ADAZ
CSB-BP719473ADAZ
CSB-MP719473ADAZ
CSB-EP719473ADAZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acanthamoeba polyphaga mimivirus Uncharacterized protein L683 (MIMI_L683) CSB-YP719474ADAZ
CSB-EP719474ADAZ
CSB-BP719474ADAZ
CSB-MP719474ADAZ
CSB-EP719474ADAZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acanthamoeba polyphaga mimivirus Uncharacterized protein R691 (MIMI_R691) CSB-YP719475ADAZ
CSB-EP719475ADAZ
CSB-BP719475ADAZ
CSB-MP719475ADAZ
CSB-EP719475ADAZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acanthamoeba polyphaga mimivirus Uncharacterized protein R705 (MIMI_R705) CSB-YP719476ADAZ
CSB-EP719476ADAZ
CSB-BP719476ADAZ
CSB-MP719476ADAZ
CSB-EP719476ADAZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acanthamoeba polyphaga mimivirus Uncharacterized protein R703 (MIMI_R703) CSB-YP719477ADAZ
CSB-EP719477ADAZ
CSB-BP719477ADAZ
CSB-MP719477ADAZ
CSB-EP719477ADAZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acanthamoeba polyphaga mimivirus Putative ankyrin repeat protein L715 (MIMI_L715) CSB-YP719478ADAZ
CSB-EP719478ADAZ
CSB-BP719478ADAZ
CSB-MP719478ADAZ
CSB-EP719478ADAZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acanthamoeba polyphaga mimivirus Putative cfxQ-like protein R730 (MIMI_R730) CSB-YP719479ADAZ
CSB-EP719479ADAZ
CSB-BP719479ADAZ
CSB-MP719479ADAZ
CSB-EP719479ADAZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acanthamoeba polyphaga mimivirus Putative ankyrin repeat protein R734 (MIMI_R734), partial CSB-YP719480ADAZ
CSB-EP719480ADAZ
CSB-BP719480ADAZ
CSB-MP719480ADAZ
CSB-EP719480ADAZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acanthamoeba polyphaga mimivirus Uncharacterized protein R746 (MIMI_R746) CSB-YP719481ADAZ
CSB-EP719481ADAZ
CSB-BP719481ADAZ
CSB-MP719481ADAZ
CSB-EP719481ADAZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acanthamoeba polyphaga mimivirus Putative ankyrin repeat protein R848 (MIMI_R848) CSB-YP719482ADAZ
CSB-EP719482ADAZ
CSB-BP719482ADAZ
CSB-MP719482ADAZ
CSB-EP719482ADAZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acanthamoeba polyphaga mimivirus Uncharacterized protein R869 (MIMI_R869) CSB-YP719483ADAZ
CSB-EP719483ADAZ
CSB-BP719483ADAZ
CSB-MP719483ADAZ
CSB-EP719483ADAZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acanthamoeba polyphaga mimivirus Uncharacterized protein L872 (MIMI_L872) CSB-YP719484ADAZ
CSB-EP719484ADAZ
CSB-BP719484ADAZ
CSB-MP719484ADAZ
CSB-EP719484ADAZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acanthamoeba polyphaga mimivirus Uncharacterized protein R587 (MIMI_R587) CSB-YP719485ADAZ
CSB-EP719485ADAZ
CSB-BP719485ADAZ
CSB-MP719485ADAZ
CSB-EP719485ADAZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>